Press Release|Articles|June 3, 2025
Camber Pharmaceuticals Announces Addition of Olmesartan Medoxomil Tablets, USP
Listen
0:00 / 0:00
Key Takeaways
- Camber Pharmaceuticals introduces Olmesartan Medoxomil Tablets, USP, for hypertension treatment in adults and children aged six and older.
- The tablets are available in 5 mg, 20 mg, and 40 mg strengths, packaged in bottles of 30 and 90 tablets.
Advertisement
Camber Pharmaceuticals is excited to announce the addition of Olmesartan Medoxomil Tablets, USP, to its current portfolio.
Olmesartan Medoxomil Tablets, USP are indicated for the treatment of hypertension in adults and children six years of age and older to lower blood pressure.
Olmesartan Medoxomil Tablets, USP, are available in 5 mg, 20 mg, and 40 mg strengths, packaged in bottles of 30 and 90 tablets.
To find out more information on Olmesartan Medoxomil Tablets, USP, please visit:
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
CKD Outcome Set Elevates Patient-Reported Measures
2
FDA Expands Accelerated Approval of Sevabertinib to First-Line HER2-Mutant NSCLC
3
In-Hospital Dapagliflozin Speeds Decongestion in Heart Failure
4
Tozorakimab Reduces COPD Exacerbations Across Eosinophil Levels in Phase 3 Trials
5